Terms: = Lung cancer AND SRSF2, Q01130, 6427, SFRS2
13 results:
1. Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study.
Versluis J; Saber W; Tsai HK; Gibson CJ; Dillon LW; Mishra A; McGuirk J; Maziarz RT; Westervelt P; Hegde P; Mukherjee D; Martens MJ; Logan B; Horowitz M; Hourigan CS; Nakamura R; Cutler C; Lindsley RC;
J Clin Oncol; 2023 Oct; 41(28):4497-4510. PubMed ID: 37607457
[TBL] [Abstract] [Full Text] [Related]
2. Expression and prognostic role of STAT5a across cancer types.
Maninang C; Li J; Li WX
Biosci Rep; 2023 Aug; 43(8):. PubMed ID: 37369132
[TBL] [Abstract] [Full Text] [Related]
3. Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.
Gumuser ED; Schuermans A; Cho SMJ; Sporn ZA; Uddin MM; Paruchuri K; Nakao T; Yu Z; Haidermota S; Hornsby W; Weeks LD; Niroula A; Jaiswal S; Libby P; Ebert BL; Bick AG; Natarajan P; Honigberg MC
J Am Coll Cardiol; 2023 May; 81(20):1996-2009. PubMed ID: 37197843
[TBL] [Abstract] [Full Text] [Related]
4. Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis.
Weinstock JS; Gopakumar J; Burugula BB; Uddin MM; Jahn N; Belk JA; Bouzid H; Daniel B; Miao Z; Ly N; Mack TM; Luna SE; Prothro KP; Mitchell SR; Laurie CA; Broome JG; Taylor KD; Guo X; Sinner MF; von Falkenhausen AS; Kääb S; Shuldiner AR; O'Connell JR; Lewis JP; Boerwinkle E; Barnes KC; Chami N; Kenny EE; Loos RJF; Fornage M; Hou L; Lloyd-Jones DM; Redline S; Cade BE; Psaty BM; Bis JC; Brody JA; Silverman EK; Yun JH; Qiao D; Palmer ND; Freedman BI; Bowden DW; Cho MH; DeMeo DL; Vasan RS; Yanek LR; Becker LC; Kardia SLR; Peyser PA; He J; Rienstra M; Van der Harst P; Kaplan R; Heckbert SR; Smith NL; Wiggins KL; Arnett DK; Irvin MR; Tiwari H; Cutler MJ; Knight S; Muhlestein JB; Correa A; Raffield LM; Gao Y; de Andrade M; Rotter JI; Rich SS; Tracy RP; Konkle BA; Johnsen JM; Wheeler MM; Smith JG; Melander O; Nilsson PM; Custer BS; Duggirala R; Curran JE; Blangero J; McGarvey S; Williams LK; Xiao S; Yang M; Gu CC; Chen YI; Lee WJ; Marcus GM; Kane JP; Pullinger CR; Shoemaker MB; Darbar D; Roden DM; Albert C; Kooperberg C; Zhou Y; Manson JE; Desai P; Johnson AD; Mathias RA; ; Blackwell TW; Abecasis GR; Smith AV; Kang HM; Satpathy AT; Natarajan P; Kitzman JO; Whitsel EA; Reiner AP; Bick AG; Jaiswal S
Nature; 2023 Apr; 616(7958):755-763. PubMed ID: 37046083
[TBL] [Abstract] [Full Text] [Related]
5. Comparison of Carboplatin With Cisplatin in Small Cell lung cancer in US Veterans.
Azar I; Yazdanpanah O; Jang H; Austin A; Kim S; Chi J; Alkassis S; Saha BK; Chopra A; Neu K; Mehdi S; Mamdani H
JAMA Netw Open; 2022 Oct; 5(10):e2237699. PubMed ID: 36264573
[TBL] [Abstract] [Full Text] [Related]
6. lncRNA MRUL Suppressed Non-Small Cell lung cancer Cells Proliferation and Invasion by Targeting miR-17-5p/srsf2 Axis.
Chen Y; Shen T; Ding X; Ma C; Cheng L; Sheng L; Du X
Biomed Res Int; 2020; 2020():9567846. PubMed ID: 33123591
[TBL] [Abstract] [Full Text] [Related]
7. Causes of death among women with epithelial ovarian cancer by length of survival post-diagnosis: a population-based study in British Columbia, Canada.
Arora N; Talhouk A; McAlpine JN; Law MR; Hanley GE
Int J Gynecol Cancer; 2019 Mar; 29(3):593-598. PubMed ID: 30821698
[TBL] [Abstract] [Full Text] [Related]
8. A VEGF-A/SOX2/srsf2 network controls VEGFR1 pre-mRNA alternative splicing in lung carcinoma cells.
Abou Faycal C; Gazzeri S; Eymin B
Sci Rep; 2019 Jan; 9(1):336. PubMed ID: 30674935
[TBL] [Abstract] [Full Text] [Related]
9. Splicing factor mutations and cancer.
Yoshida K; Ogawa S
Wiley Interdiscip Rev RNA; 2014; 5(4):445-59. PubMed ID: 24523246
[TBL] [Abstract] [Full Text] [Related]
10. A dedicated microarray for in-depth analysis of pre-mRNA splicing events: application to the study of genes involved in the response to targeted anticancer therapies.
Pesson M; Eymin B; De La Grange P; Simon B; Corcos L
Mol Cancer; 2014 Jan; 13():9. PubMed ID: 24428911
[TBL] [Abstract] [Full Text] [Related]
11. A new function of the splicing factor srsf2 in the control of E2F1-mediated cell cycle progression in neuroendocrine lung tumors.
Edmond V; Merdzhanova G; Gout S; Brambilla E; Gazzeri S; Eymin B
Cell Cycle; 2013 Apr; 12(8):1267-78. PubMed ID: 23518498
[TBL] [Abstract] [Full Text] [Related]
12. Abnormal expression of the pre-mRNA splicing regulators SRSF1, srsf2, SRPK1 and SRPK2 in non small cell lung carcinoma.
Gout S; Brambilla E; Boudria A; Drissi R; Lantuejoul S; Gazzeri S; Eymin B
PLoS One; 2012; 7(10):e46539. PubMed ID: 23071587
[TBL] [Abstract] [Full Text] [Related]
13. srsf2 is required for sodium butyrate-mediated p21(WAF1) induction and premature senescence in human lung carcinoma cell lines.
Edmond V; Brambilla C; Brambilla E; Gazzeri S; Eymin B
Cell Cycle; 2011 Jun; 10(12):1968-77. PubMed ID: 21555914
[TBL] [Abstract] [Full Text] [Related]
